Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

NCT01928472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

H7N9 Influenza

Interventions

BIOLOGICAL: H7N9c low dose with adjuvant
BIOLOGICAL: H7N9c medium dose with adjuvant
BIOLOGICAL: H7N9c high dose with adjuvant
BIOLOGICAL: H7N9c high dose without adjuvant

Sponsor

Novartis Vaccines